In 1979, Deng Xiaoping drew "a circle" on the southern shore of the South China Sea.
40 years later, Shenzhen — once an obscure "small fishing village" — has leapt into one of the country's economic centers, a national innovation city, and an international science and technology industrial innovation center.
This is thanks to Shenzhen's gathering of outstanding talent and innovation-driven development.
The founder of Beike Biotech, Hu Xiang, is one of these outstanding individuals.
On January 14, 2019, Dr. Hu Xiang, Chairman of Beike Biotech, attended the Awards Ceremony of the 5th Shenzhen Entrepreneurs Global Conference and was honored as a 2018 "11th Shenzhen Entrepreneur of the Year."
Dr. Hu Xiang, Chairman of Beike Biotech, attended the Awards Ceremony of the 5th Shenzhen Entrepreneurs Global Conference and was honored as a 2018 "11th Shenzhen Entrepreneur of the Year."
He also delivered an excellent speech at the Conference's "Backbone of a Great Nation, the Spirit of Craftsmanship — Manufacturing Forum," exemplifying the leadership style of a top Shenzhen entrepreneur shaping China!
Themed "Backbone of a Great Nation, the Spirit of Craftsmanship, Manufacturing Life and Manufacturing with Life," Dr. Hu Xiang led the audience into a brand-new era of life sciences, in which humanity is now reaching into previously unknown areas of itself, such as cells, stem cells, and the regenerative medicine that grows from them. Below are excerpts from Dr. Hu Xiang's speech:
"In the future, treating disease will not depend on chemical drugs but mainly on using one's own cells to treat one's own disease. Cell therapy will become a pillar of the future of medicine.
Manufacturing with life means the spirit of craftsmanship. Many think it's easy to make a batch of cells — humming a tune in the lab and the cells appear. That's not the case. To do so for 100,000 or even 1 million people in a repeatable, problem-free way, you must build a complete quality control system. For every cell sample stored at the Shenzhen Cell Preparation Center, there are more than 580 standard documents, more than 740 quality records, and up to more than 910 quality control checkpoints involving testing or confirmation. We have to build this standard and this system, and drive the industry forward."
Authoritative third-party certifications obtained by Beike Biotech in the biotech industry
With 13 years of dedication, professionalism, and focus on the cell field, Beike Biotech has a strong R&D team in this field. To date, it has filed 85 patents in the biomedical field, with 40 of them granted; it has undertaken 66 national, provincial and municipal scientific research projects including 863 Programs and Torch Programs; and it has published more than 100 papers in journals such as Cell Stem Cell.
In December 2015, the National Development and Reform Commission approved Beike Biotech to construct the "National-Local Joint Engineering Laboratory of Personalized Cell Therapy Technology." This laboratory is China's national-level technology development and translation platform for advancing the clinical translation of personalized cell therapy technology.
